Alnylam Pharmaceuticals, Inc.
ALNY
Revenue
593.17M
▲92.25M▲18.42%
3 Months ChangeAssets
4.24B
▲34.94M▲0.8310%
3 Months ChangeLiabilities
4.17B
▲210.00k▲0.005033%
3 Months ChangeFree Cash Flow
-94.49M
▲85.88M▲47.61%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0001178670-24-000053
2024-10-31
Form 8-K
ID: 0001178670-24-000052
2024-08-01
Form 10-Q
ID: 0001178670-24-000041
2024-08-01
Form 8-K
ID: 0001178670-24-000039
2024-05-20
Form 8-K
ID: 0001178670-24-000027
2024-05-02
Form 10-Q
ID: 0001178670-24-000023
2024-05-02
Form 8-K
ID: 0001178670-24-000021
2024-03-04
Form 8-K
ID: 0001193125-24-057906
2024-02-15
Form 8-K
ID: 0001157523-24-000253
2024-01-19
Form 8-K
ID: 0001193125-24-011278